Spectrum Dynamics Medical UK Limited Filleted Accounts Cover |
Audited accounts | |||||||||
Company No. 13894573 | |||||||||
Spectrum Dynamics Medical UK Limited Directors Report Registrar |
The Directors present their report and the accounts for the year ended 31 December 2024. | |||||||||
Principal activities | |||||||||
Directors | |||||||||
The Directors who served at any time during the year were as follows: | |||||||||
T. Gabay | |||||||||
G. Yoeli | (Resigned 10 March 2025) | ||||||||
The directors are responsible for keeping adequate accounting records that show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.","The director is responsible for keeping adequate accounting records that show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. | |||||||||
Auditors | |||||||||
The auditors, Gordon Levy Limited, are deemed to be reappointed under section 487(2) of the Companies Act 2006. | |||||||||
Signed on behalf of the board | |||||||||
T. Gabay | |||||||||
Director | |||||||||
30 September 2025 | |||||||||
Spectrum Dynamics Medical UK Limited Balance Sheet Registrar |
at | ||||||||||
Company No. | Notes | 2024 | 2023 | |||||||
£ | £ | |||||||||
Fixed assets | ||||||||||
Tangible assets | 4 | |||||||||
Current assets | ||||||||||
Stocks | 5 | |||||||||
Debtors | 6 | |||||||||
Cash at bank and in hand | ||||||||||
Creditors: Amount falling due within one year | 7 | ( | ( | |||||||
Net current assets | ||||||||||
Total assets less current liabilities | ||||||||||
Net assets | ||||||||||
Capital and reserves | ||||||||||
Called up share capital | ||||||||||
Profit and loss account | 9 | |||||||||
Total equity | ||||||||||
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. | ||||||||||
As permitted by section 444 (5A)of the Companies Act 2006 the directors have not delivered to the Registrar a copy of the company's profit and loss account. | ||||||||||
Approved by the board on 30 September 2025 and signed on its behalf by: | ||||||||||
T. Gabay | ||||||||||
Director | ||||||||||
30 September 2025 | ||||||||||
Spectrum Dynamics Medical UK Limited Notes to the Accounts Registrar |
for the year ended 31 December 2024 | ||||||||||||||
1 | General information | |||||||||||||
Spectrum Dynamics Medical UK Limited is a private company limited by shares and incorporated in England and Wales. | ||||||||||||||
The company's registered number is: 13894573 | ||||||||||||||
The address of the company's registered office is: | ||||||||||||||
Going concern | ||||||||||||||
2 | Accounting policies | |||||||||||||
Turnover | ||||||||||||||
Revenue from the sale of goods is recognised when all the following conditions are satisfied: • the Company has transferred to the buyer the significant risks and rewards of ownership of the goods; • the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold; • the amount of revenue can be measured reliably; • it is probable that the economic benefits associated with the transaction will flow to the Company; and • the costs incurred or to be incurred in respect of the transaction can be measured reliably. Specifically, revenue from the sale of goods is recognised when goods are delivered and legal title is passed. | ||||||||||||||
Revenue for provision of services is recognised when it is probable that an economic benefit will flow to the entity and the revenue and costs can be reliably measured. For continuing services, revenue is recognised when the stage of completion can be reliably measured using a percentage of completion method. | ||||||||||||||
Tangible fixed assets and depreciation | ||||||||||||||
At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss. | ||||||||||||||
Plant and machinery | ||||||||||||||
Taxation | ||||||||||||||
Income tax expense represents the sum of the tax currently payable and deferred tax. The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period. | ||||||||||||||
Stocks | ||||||||||||||
Stocks are stated at the lower of cost and net realisable value. Net realisable value is based upon estimated selling prices less further costs expected to be incurred to disposal. | ||||||||||||||
At each balance sheet date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in the statement of comprehensive income. | ||||||||||||||
Trade and other debtors | ||||||||||||||
Trade and other creditors | ||||||||||||||
Foreign currencies | ||||||||||||||
Judgements and key sources of estimation uncertainty | ||||||||||||||
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors including expectations of future events that are believed to be reasonable under the circumstances. | ||||||||||||||
Cash and cash equivalents | ||||||||||||||
Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value. | ||||||||||||||
3 | Employees | |||||||||||||
2024 | 2023 | |||||||||||||
Number | Number | |||||||||||||
The average monthly number of employees (including directors) during the year was: | ||||||||||||||
4 | Tangible fixed assets | |||||||||||||
Fixtures, fittings and equipment | Total | |||||||||||||
£ | £ | |||||||||||||
Cost or revaluation | ||||||||||||||
At 1 January 2024 | ||||||||||||||
At 31 December 2024 | ||||||||||||||
Depreciation | ||||||||||||||
At 1 January 2024 | ||||||||||||||
Charge for the year | ||||||||||||||
At 31 December 2024 | ||||||||||||||
Net book values | ||||||||||||||
At 31 December 2024 | ||||||||||||||
At 31 December 2023 | 2,912 | |||||||||||||
5 | Stocks | |||||||||||||
2024 | 2023 | |||||||||||||
£ | £ | |||||||||||||
Finished goods | ||||||||||||||
6 | Debtors | |||||||||||||
2024 | 2023 | |||||||||||||
£ | £ | |||||||||||||
Trade debtors | ||||||||||||||
Amounts owed by group undertakings | ||||||||||||||
Prepayments and accrued income | ||||||||||||||
7 | Creditors: | |||||||||||||
amounts falling due within one year | ||||||||||||||
2024 | 2023 | |||||||||||||
£ | £ | |||||||||||||
Trade creditors | ||||||||||||||
Amounts owed to group undertakings | ||||||||||||||
Taxes and social security | ||||||||||||||
Accruals and deferred income | ||||||||||||||
8 | Share Capital | |||||||||||||
The company has issued 100 ordinary shares, fully paid, of £1 each, amounting to a share capital of £100. | ||||||||||||||
9 | Reserves | |||||||||||||
10 | Related party disclosures | |||||||||||||
Transactions with related parties | ||||||||||||||
The company has taken advantage of the exemption according to FRS 102 1A "Related party disclosure" not to disclose transactions entered into between two or more members of a group that are wholly owned. | ||||||||||||||
Parent Company | ||||||||||||||
The name of the parent of the smallest group for which consolidated financial statements are drawn up of which this entity is a member: | ||||||||||||||
Spectrum Dynamics Medical Group Limited | ||||||||||||||
The parent's registered office address is: | ||||||||||||||
PO BOX 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands | ||||||||||||||